Senseonics brings on Francine Kaufman as chief medical officer

boardroom
Kaufman has served as head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles, as well as chair of the National Diabetes Education Program. (Pixabay)

Francine Kaufman, former president of the American Diabetes Association and most recently chief medical officer for Medtronic Diabetes, has joined continuous glucose monitor developer Senseonics as its new CMO.

The company hopes the hire will help bolster the U.S. commercialization of its implantable, 90-day Eversense CGM system, which kicked off last summer, as well as support Senseonics’ clinical development and validation efforts.

“Fran is one of the world’s leading endocrinologists and her deep understanding of the global medical, research, and clinical diabetes community coupled with her track record of applying novel technologies to advance diabetes care for patients make her ideally suited for the role,” Senseonics President and CEO Tim Goodnow said in a statement.

Training Course

BioBasics: Biotech For The Non-Scientist

BioBasics: Biotech for the Non-Scientist is a two-day course for those who want to better understand the science driving the industry. The course starts with basic scientific concepts and quickly delves into the causes of genetic and infectious disease and the therapeutic strategies used to mitigate disease. The latest innovations in immunotherapies, gene therapy, checkpoint inhibitors, CAR-T and more are explained.

Kaufman’s career as a pediatric endocrinologist has included turns as director of the Comprehensive Childhood Diabetes Center and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles, as well as chair of the National Diabetes Education Program.

RELATED: Roche, Senseonics extend diabetes monitor distribution deal to BRIC countries

She is also a distinguished professor emerita of pediatrics and communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California, and has served as an adviser to the governor of California on health, fitness and obesity. At Medtronic Diabetes, she also served as VP of global clinical, regulatory and medical affairs, and was elected to the National Academy of Medicine.

“I am very excited to join the Senseonics team, especially at this point where I feel I have an opportunity to help lay the foundation for the first long-term implantable continuous glucose monitoring system,” Kaufman said.

Suggested Articles

The Chan Zuckerberg Initiative is awarding $17 million for advances in digital microscopy to allow researchers to view the subtleties of disease.

The drug failed to clearly outperform a generic used as a control, leaving room to doubt whether vibegron poses a big threat to Astellas’ Myrbetriq.

The level of interest in gene therapies has been laid bare by a report on Biogen’s pursuit of Nightstar Therapeutics.